Guizhou Xinbang Pharmaceutical

Guizhou Xinbang Pharmaceutical is a company listed under the stock ticker 002390 (CN).

View the org chart displaying its 14 main executives

Most searched biographies at Guizhou Xinbang Pharmaceutical

• Lingzhong Kong, General Manager
• Ji An, Chairman of the Board
• Jun Zhou, Independent Director

Create your alert
to follow the executive moves at Guizhou Xinbang Pharmaceutical.

Guizhou Xinbang Pharmaceutical has 1,863 competitors including Pfizer (United States (USA)), Sanofi (France) and Johnson & Johnson (United States (USA)).

Popular M&A news in Pharmaceuticals

• AstraZeneca has announced the acquisition of Fusion Pharma  (posted on March 23 2024).
• AstraZeneca has announced the acquisition of Amolyt Pharma  (posted on March 19 2024).
• Frontier Medicines has just announced a $80 Million fundraising (posted on February 27 2024).

Popular contacts in Pharmaceuticals

• Jean-Frédéric Paulsen - Executive Chairman of the Board at Ferring Pharmaceuticals
• Alice Schardt-Rossmann - Managing Director at Dirk Rossmann
• Thierry Abribat - Chief Executive Officer at Amolyt Pharma

Learn more about the Pharmaceuticals industry >

Press releases by Guizhou Xinbang Pharmaceutical

• 巨潮资讯网
• 巨潮资讯网
• 巨潮资讯网
• 巨潮资讯网
• 巨潮资讯网
• 巨潮资讯网
• 巨潮资讯网
• 巨潮资讯网
• 巨潮资讯网
• 巨潮资讯网
• View more press releases Close

Social media about Guizhou Xinbang Pharmaceutical

• Guizhou Xinbang Pharmaceutical on Wikipedia, Google News & Yahoo Finance
• Guizhou Xinbang Pharmaceutical on LinkedIn, Twitter & YouTube

Call Guizhou Xinbang Pharmaceutical at +86 851 ...

View the org chart

Register to receive your alert

Report an error